- Shareholders meeting's resolution

- Publication of the Invitation to the 2026 Annual General Meeting of Shareholders on the Company's Website

- Resolutions of the Board of Directors' Meeting on the appointment to replace the retiring director, Dividend Payment and Schedule for Annual General Meeting of Shareholders 2026

- Management Discussion and Analysis Yearly Ending 31 Dec 2025

- Financial Statement Yearly 2025 (Audited)

- Financial Performance Yearly (F45) (Audited)

- New shares of BRR to be traded on February 26, 2026

- Report on the results of the Last Exercise of BRR-W2 (F53-5)

- Appointment of Chairman of the Board of Director, Chairman of Audit Committee and Sub Committee (Revised)

- Appointment of Chairman of the Board of Director, Chairman of Audit Committee and Sub Committee

- 20 January 2026 is the last trading day of BRR-W2

- Trading Suspension and termination of listing status of BRR-W2

- Notification the final exercise and request for suspension of BRR-W2

- Report on the results of the Exercise of BRR-W2 (F53-5)

- Independent Director

- Notification the exercise of BRR-W2 (11th Exercise)

- Financial Statement Quarter 3/2025 (Reviewed)

- Financial Performance Quarter 3 (F45) (Reviewed)

- Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025

- Invitation to Shareholders to Propose the 2026 Annual General Shareholder's Meeting Agenda, Nominate Director Candidates, and Submit Questions in Advance